Partners & Customers
10About StarFish Medical
StarFish Medical is a full service Medical Device Design company with product design, development, and manufacturing services. The firm uses Pathfinder, a process to reduce wasted effort and increase success for medical device product definition, technical engineering, and product development.
Want to inform investors similar to StarFish Medical about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest StarFish Medical News
Aug 23, 2023
Life Sciences British Columbia All News August 22, 2023 StarFish Medical VICTORIA, BC — StarFish Medical, Canada’s largest medical device design company, will exhibit in booth 620 at BIOMEDevice Boston 2023, September 20-21, 2023 at the Convention & Exhibition Center in Boston, MA. Are you hoping to connect about building and commercializing medial devices or other matters related to medical medical device design or manufacturing? Visit the StarFish Medical BIOMEDevice Boston 2023 exhibitor website for a virtual tour. About BIOMEDevice Boston 2023 BIOMEDevice Boston 2023 is the Region’s Epicenter for Innovation and brings engineers, business leaders, disruptive companies, and innovative thinkers from the region’s top start-ups and medical device OEMs together to inspire the next life-changing medical device. It provides the platform for taking an innovative solution from a concept to a full-fledged product by bringing together the brightest minds in 3D printing, digital health, surgical robotics, and more. – 1,400+ attendees About StarFish Medical Empowering Medtech Innovation ® StarFish Medical is an award winning, full service Medical Device Design company offering design, development, and NPI manufacturing services based in Toronto and Victoria BC. Our Pathfinder™ process reduces wasted effort and increases success for medical device product definition, technical engineering, and product development. Prototype and volume production are delivered within an ISO 13485 certified Quality Management System, manufacturing and clean room facilities. StarFish Medical specialty areas include: Bio Services including Microfluidics, Regenerative Medicine, and Microbiology, Cardiovascular, Connected Devices, IVD, Ophthalmology, Optics, Point of Care Assays, Ultrasound, Anesthesiology, Respiratory, Dental, Dermatology, Diabetes, Drug-Delivery/Combination Products, Ear, Nose, and Throat, Gastroenterology and Urology, General and Plastic Surgery, General Hospital Equipment and Supplies, Clinical Chemistry, Neurology, Obstetrical, Gynecological, and Women’s Health, Oncology, Ophthalmic, Orthopedic, Pediatric, Radiological, Imaging, and Electromechanical, Rehabilitation and Assistive-Technology, Respiratory. Empowering Medtech Innovation®. www.starfishmedical.com
StarFish Medical Acquisitions
1 Acquisition
StarFish Medical acquired 1 company. Their latest acquisition was Kangaroo Group on March 28, 2017.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
3/28/2017 | Merger | 1 |
Date | 3/28/2017 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Merger |
Sources | 1 |
StarFish Medical Partners & Customers
10 Partners and customers
StarFish Medical has 10 strategic partners and customers. StarFish Medical recently partnered with Cybeats on May 5, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
5/22/2023 | Licensor | Canada | StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including stem cell therapies , biomanufacturing , assay integrations , microfluidic prototyping , and In-Vitro Diagnostics . | 2 | |
7/8/2022 | Partner | Canada | NGen Funds Development of Novel Bioink for Generating Human Brain Tissue. HAMILTON , ON , July 8 , 2022 -- Next Generation Manufacturing Canada has announced $ 265k in co-funding , for a project led by Canadian biotechnology company Axolotl Biosciences in partnership with StarFish Medical to scale-up the production of BrainPrint bioink . | 1 | |
10/26/2021 | Client | Canada | StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including : Digital Health , Cardiovascular , Neurology , Urology , Gastroenterology , Otology , Ophthalmology , and In-Vitro Diagnostics . | 2 | |
7/22/2021 | Vendor | ||||
7/22/2021 | Vendor |
Date | 5/22/2023 | 7/8/2022 | 10/26/2021 | 7/22/2021 | 7/22/2021 |
|---|---|---|---|---|---|
Type | Licensor | Partner | Client | Vendor | Vendor |
Business Partner | |||||
Country | Canada | Canada | Canada | ||
News Snippet | StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including stem cell therapies , biomanufacturing , assay integrations , microfluidic prototyping , and In-Vitro Diagnostics . | NGen Funds Development of Novel Bioink for Generating Human Brain Tissue. HAMILTON , ON , July 8 , 2022 -- Next Generation Manufacturing Canada has announced $ 265k in co-funding , for a project led by Canadian biotechnology company Axolotl Biosciences in partnership with StarFish Medical to scale-up the production of BrainPrint bioink . | StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including : Digital Health , Cardiovascular , Neurology , Urology , Gastroenterology , Otology , Ophthalmology , and In-Vitro Diagnostics . | ||
Sources | 2 | 1 | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
